To the full analysis
Buyback calculator for BioNTech
BioNTech stock: key metrics
BNTXBioNTech had an operating margin of −22.6% and a return on invested capital (ROIC) of −13.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2017 | 84.9% | −99.5% | −139.1% |
| 2018 | 89.3% | −42.2% | −37.6% |
| 2019 | 84.0% | −167.1% | −164.9% |
| 2020 | 87.7% | −17.1% | 3.2% |
| 2021 | 84.7% | 80.5% | 54.2% |
| 2022 | 82.7% | 73.0% | 54.5% |
| 2023 | 84.3% | 18.1% | 24.4% |
| 2024 | 80.3% | −47.8% | −24.2% |
| 2025 | 77.6% | −22.6% | −39.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2017 | 173.8% | −17.6% | −22.9% |
| 2018 | −18.0% | −11.5% | −7.4% |
| 2019 | −36.3% | −24.1% | −22.5% |
| 2020 | 1.1% | −5.5% | 0.7% |
| 2021 | 86.5% | 201.3% | 65.0% |
| 2022 | 47.0% | 112.8% | 40.5% |
| 2023 | 4.6% | 10.7% | 4.0% |
| 2024 | −3.4% | −30.5% | −3.0% |
| 2025 | −5.7% | −13.1% | −5.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 12 Sep 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.